TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17002609

Group type: EXPERIMENTAL
Intervention: Clinical response during the first days of treatment
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Altered mental state
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Arterial PaH <7.35 mm Hg
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: PaO2 <60 mm Hg
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: History of heart failure
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Patients who failed to respond
Number of subjects: 260
Study: 14643272

Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 1749
Study: 10955871

Group type: EXPERIMENTAL
Intervention: ACE with lenograstim support (150 microg/m2/day subcutaneously, days 4-13)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: ACE with lenograstim support
Number of subjects: 280

Group type: COMPARATOR
Intervention: ACE alone
Number of subjects: 280
Study: 8834690

Group type: EXPERIMENTAL
Intervention: Experimental biphasic waveform (LVLD) with a single 450-microF capacitor and 60% tilt
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard biphasic waveform (STD) with two 250-microF capacitors in series and 80% tilt
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both waveforms (STD and LVLD)
Number of subjects: 25
Study: 1427379

Group type: EXPERIMENTAL
Intervention: Acarbose (100 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Miglitol (100 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 3900796

Group type: EXPERIMENTAL
Intervention: Milenperone (2 X 10 mg daily for 6 weeks)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: COMPARATOR
Intervention: Milenperone or Placebo
Number of subjects: 21
Study: 30891608

Group type: EXPERIMENTAL
Intervention: ICD recipients aged ≥80 years
Number of subjects: 300

Group type: COMPARATOR
Intervention: Controls aged <80 years
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Elderly group
Number of subjects: 300
Study: 29566987

Group type: EXPERIMENTAL
Intervention: Artificial collagen nerve conduit
Number of subjects: 49

Group type: COMPARATOR
Intervention: Autologous nerve graft
Number of subjects: 49
Study: 27823996

Group type: EXPERIMENTAL
Intervention: Qinming8631 DR
Number of subjects: 225

Group type: COMPARATOR
Intervention: Talos DR
Number of subjects: 225
Study: 25299041

Group type: EXPERIMENTAL
Intervention: Caseation
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Confluent granulomas
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Ulcers lined by epithelioid histiocytes
Number of subjects: 692
Study: 23106881

Group type: EXPERIMENTAL
Intervention: Modified nephroureterectomy (clipping the distal ureter prior to NU)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Standard nephroureterectomy (traditional standard NU)
Number of subjects: 85
Study: 20673500

Group type: EXPERIMENTAL
Intervention: Fast track surgery (FTS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional methods (Control)
Number of subjects: 80
Study: 19029267

Group type: EXPERIMENTAL
Intervention: On-pump CABG
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 44

Group type: COMPARATOR
Intervention: Comparison between on-pump and off-pump CABG
Number of subjects: 44
Study: 15918827

Group type: EXPERIMENTAL
Intervention: Endovascular occlusion of the aneurysm using detachable coils
Number of subjects: 34

Group type: COMPARATOR
Intervention: Craniotomy and clipping of the aneurysm
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Peri‐operative care for patients undergoing interventional neuroradiology procedures
Number of subjects: 34
Study: 12884417

Group type: EXPERIMENTAL
Intervention: CARE intervention program
Number of subjects: 49

Group type: COMPARATOR
Intervention: Comparison program
Number of subjects: 49
Study: 10727924

Group type: EXPERIMENTAL
Intervention: Thulium-YAG laser stimulation (540 mJ pulses)
Number of subjects: 23
Study: 8772689

Group type: EXPERIMENTAL
Intervention: Plasma norepinephrine (PNE) levels above the median of 393 pg/mL
Number of subjects: 514
Study: 1471822

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 101

Group type: COMPARATOR
Intervention: Radiation therapy
Number of subjects: 101
Study: 6419264

Group type: EXPERIMENTAL
Intervention: 3-cyano-imipramine (1 mg rising to 3 mg daily for 7 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29107059

Group type: EXPERIMENTAL
Intervention: NEMEX (neuromuscular exercise)
Number of subjects: 93

Group type: COMPARATOR
Intervention: PHARMA (optimized pharmacological treatment)
Number of subjects: 93
Study: 23283758

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) at a dosage of .3 mg/kg
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 25823758

Group type: EXPERIMENTAL
Intervention: Detailed instructions regarding the infant's environment, positioning, and handling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard positioning instructions to prevent SIDS
Number of subjects: 0
Study: 23506414

Group type: EXPERIMENTAL
Intervention: Bonfils fiberscope (BF)
Number of subjects: 100

Group type: COMPARATOR
Intervention: GlideScope (GS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Direct laryngoscopy (DL)
Number of subjects: 100
Study: 21962090

Group type: EXPERIMENTAL
Intervention: FAN educational program
Number of subjects: 275

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 275
Study: 18376536

Group type: EXPERIMENTAL
Intervention: Auditory mode for steering task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual mode for steering task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auditory mode for monitoring task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual mode for monitoring task
Number of subjects: 0
Study: 16490069

Group type: EXPERIMENTAL
Intervention: Traditional roles of health teams in elementary schools (providing first aid, ensuring school hygiene)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Evaluation of students with behavioral problems, Evaluation of students with low academic performance, Follow up and care of students with behavioral problems and low performance
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Social-based model of health services in schools
Number of subjects: 35
Study: 12806341

Group type: EXPERIMENTAL
Intervention: 37% phosphoric acid etching before bonding metallic premolar brackets (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide bleaching agent, bonded immediately (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide bleaching agent, stored in artificial saliva for 30 days before bonding (Group C)
Number of subjects: 60
Study: 10827367

Group type: EXPERIMENTAL
Intervention: TEE‐guided subcutaneous enoxaparin bridge therapy
Number of subjects: 200

Group type: COMPARATOR
Intervention: TEE‐guided intravenous unfractionated heparin bridge therapy
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 200
Study: 8648019

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1513578

Group type: EXPERIMENTAL
Intervention: Heparin surface modified IOL
Number of subjects: 524

Group type: COMPARATOR
Intervention: Conventional PMMA IOL
Number of subjects: 524
Study: 6526768

Group type: EXPERIMENTAL
Intervention: Contingent reinforcement with varying pay amounts ($0, $1.50, $3, $6, $12 per day) for reduced afternoon CO levels
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Contingent reinforcement with varying pay amounts
Number of subjects: 23
Study: 29276837

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) in lung cancer patients (4 sessions)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) in breast cancer patients (6 sessions)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group for lung cancer patients (4 sessions)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group for breast cancer patients (6 sessions)
Number of subjects: 258
Study: 28666310

Group type: EXPERIMENTAL
Intervention: Self-management support (SMS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Common intervention (CI)
Number of subjects: 90
Study: 26531095

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 supplementation (1800 mg per day)
Number of subjects: 20
Study: 25294055

Group type: EXPERIMENTAL
Intervention: SaiLuoTong 360 mg per day for 52 weeks
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: SaiLuoTong 240 mg per day for 52 weeks
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo during the double-blind phase
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: SaiLuoTong 360 mg per day during the extension phase
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: SaiLuoTong 240 mg per day during the extension phase
Number of subjects: 372
Study: 22459341

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 19653976

Group type: EXPERIMENTAL
Intervention: Testosterone gel (7.5 g daily for 12 weeks)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo gel (7.5 g daily for 12 weeks)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Testosterone gel (7.5 g daily during open-label phase)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo gel (7.5 g daily during open-label phase)
Number of subjects: 33
Study: 17761977

Group type: EXPERIMENTAL
Intervention: CI-1033 50 mg daily for 21 consecutive days
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: CI-1033 150 mg daily for 21 consecutive days
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: CI-1033 450 mg daily for 14 consecutive days followed by 7 days of no treatment
Number of subjects: 166
Study: 15549466

Group type: EXPERIMENTAL
Intervention: 1% ropivacaine, 12 ml
Number of subjects: 18

Group type: COMPARATOR
Intervention: 2% mepivacaine, 18 ml
Number of subjects: 18
Study: 11593302

Group type: EXPERIMENTAL
Intervention: Leucine supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycine supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Arginine supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsupplemented diet
Number of subjects: 0
Study: 9504845

Group type: EXPERIMENTAL
Intervention: Response to faces in right occipito-temporal channels at a latency of 140 ms
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Face-specific response
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Source modelling
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Analysis of image types
Number of subjects: 14
Study: 8836468

Group type: EXPERIMENTAL
Intervention: Yohimbine (used alone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yohimbine (in combination with other drugs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other medications containing yohimbine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yohimbine (uncontrolled trials)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yohimbine plus other drugs (uncontrolled trials)
Number of subjects: 0
Study: 2271802

Group type: EXPERIMENTAL
Intervention: Group behavioral medicine interventions (two types)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Information group focusing on stress management
Number of subjects: 80
Study: 492047

Group type: EXPERIMENTAL
Intervention: 10 ml Trental (= 200 mg pentoxifylline)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Physiological saline solution (= placebo)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Baseline control
Number of subjects: 33
Study: 30865232

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 1169

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 1169

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 1169
Study: 27054321

Group type: EXPERIMENTAL
Intervention: Green tea supplementation (0.56 g/d epigallocatechin-gallate + 0.28 ∼ 0.45 g/d caffeine)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Green tea supplementation
Number of subjects: 58
Study: 24236646

Group type: EXPERIMENTAL
Intervention: Low-fat dairy (LFD)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Isocaloric control foods (CON)
Number of subjects: 35
Study: 21802739

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 38
Study: 19336626

Group type: COMPARATOR
Intervention: Coca‐Cola
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Rosehip fruit tea
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Black herbal tea
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mint‐mate herbal tea
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mint‐lemon herbal tea
Number of subjects: 90

Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 90
Study: 16689181

Group type: EXPERIMENTAL
Intervention: BB536 yoghurt (yoghurt containing Bifidobacterium longum BB536)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: BB536 yoghurt
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo yoghurt
Number of subjects: 40
Study: 15298638

Group type: EXPERIMENTAL
Intervention: Erythropoietin (100 IE/kg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 11777230

Group type: EXPERIMENTAL
Intervention: Patients with heel pain (BMI 30.4 +/- 0.7)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (BMI 28.2 +/- 0.7)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with heel pain
Number of subjects: 0
Study: 9170121

Group type: EXPERIMENTAL
Intervention: Zopiclone 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 12
Study: 1555981

Group type: EXPERIMENTAL
Intervention: Pre- or postoperative radiation therapy (45 Gy/5 weeks)
Number of subjects: 960

Group type: COMPARATOR
Intervention: Tangential 60Co fields for left-sided tumors
Number of subjects: 960

Group type: COMPARATOR
Intervention: Less radiation to the myocardium (electrons or right-sided tumors)
Number of subjects: 960
Study: 2582386

Group type: EXPERIMENTAL
Intervention: RS4 mode
Number of subjects: 18

Group type: COMPARATOR
Intervention: VVI mode
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: RS4 function
Number of subjects: 18
Study: 31215468

Group type: EXPERIMENTAL
Intervention: Holistic care program combining DMP with spiritual needs assessment and social contact/self-care exploration.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard disease management program (DMP) as usual.
Number of subjects: 0
Study: 29068050

Group type: EXPERIMENTAL
Intervention: Nose blowing at least twice daily for the first 7 postoperative days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Refraining from nose blowing
Number of subjects: 40
Study: 26980614

Group type: EXPERIMENTAL
Intervention: iTBS administered over ipsilesional primary motor cortex (M1-stimulation group)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control-stimulation group (parieto-occipital vertex)
Number of subjects: 26
Study: 25325205

Group type: EXPERIMENTAL
Intervention: 150 mg/day bupropion
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 22301476

Group type: EXPERIMENTAL
Intervention: CCIV (cell-culture-derived influenza vaccine)
Number of subjects: 3604

Group type: COMPARATOR
Intervention: TIV (conventional egg-derived trivalent influenza vaccine)
Number of subjects: 3604

Group type: EXPERIMENTAL
Intervention: CCIV
Number of subjects: 3604

Group type: COMPARATOR
Intervention: TIV
Number of subjects: 3604
Study: 20406241

Group type: EXPERIMENTAL
Intervention: Aliskiren 150 mg (up-titrated to 300 mg)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Ramipril 5 mg (up-titrated to 10 mg)
Number of subjects: 175
Study: 17623606

Group type: EXPERIMENTAL
Intervention: Intra-articular analgesic mixture (adrenaline, morphine, bupivacaine) administered during ACL reconstruction (groups 3 and 4)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Intra-articular analgesic mixture (adrenaline, morphine, bupivacaine)
Number of subjects: 85

Group type: COMPARATOR
Intervention: No intra-articular analgesic (groups 1, 2, and 5)
Number of subjects: 85
Study: 16094780

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) in Group 1 (Spastic quadriparesis patients with impaired consciousness)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) in Group 2 (Patients with upper limb spasticity)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) in Group 3 (Lower limb spasticity patients)
Number of subjects: 21
Study: 12392805

Group type: EXPERIMENTAL
Intervention: Twice weekly cognitive behavioral therapy sessions
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Once weekly cognitive behavioral therapy sessions
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Biweekly cognitive behavioral therapy sessions
Number of subjects: 68
Study: 10580197

Group type: EXPERIMENTAL
Intervention: Canarypox virus vaccine (vCP300)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control injections
Number of subjects: 23
Study: 7593700

Group type: EXPERIMENTAL
Intervention: Teflon membrane and fibrin glue
Number of subjects: 11

Group type: COMPARATOR
Intervention: Teflon membrane alone
Number of subjects: 11
Study: 2206824

Group type: EXPERIMENTAL
Intervention: Ciba-Geigy carbamazepine preparation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Ethical Generics carbamazepine preparation
Number of subjects: 23
Study: 6157949

Group type: EXPERIMENTAL
Intervention: Procainamide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ouabain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study: 31525120

Group type: EXPERIMENTAL
Intervention: Mediterranean diet intervention group
Number of subjects: 4500

Group type: COMPARATOR
Intervention: Control group (leaflet on healthy nutrition)
Number of subjects: 4500
Study: 29781243

Group type: EXPERIMENTAL
Intervention: Probiotic supplements containing Bifidobacterium and Lactobacillus
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 28544702

Group type: EXPERIMENTAL
Intervention: C15:0 blood levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: C17:0 blood levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in dairy intake (total dairy, high-fat dairy, cheese, butter)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in high-fat dairy and cream intake
Number of subjects: 0
Study: 26463717

Group type: EXPERIMENTAL
Intervention: Arthroscopic surgery
Number of subjects: 273

Group type: COMPARATOR
Intervention: Open rotator cuff repair
Number of subjects: 273
Study: 24060193

Group type: EXPERIMENTAL
Intervention: PREP (4-session, 15-hr small-group intervention)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: CARE (4-session, 15-hr small-group intervention)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: RA (1-session relationship awareness intervention)
Number of subjects: 174

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: PREP
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: CARE
Number of subjects: 174
Study: 21130513

Group type: EXPERIMENTAL
Intervention: DPP-IV inhibitor PF-734200 (multiple doses for 28 days)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 72
Study: 19608530

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg once daily
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg once daily and Aspirin 350 mg twice daily
Number of subjects: 45
Study: 17553909

Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) plus non-steroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: NSAIDs alone
Number of subjects: 0
Study: 15066879

Group type: EXPERIMENTAL
Intervention: Social Development Curriculum (SDC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: School/Community Intervention (SCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention-placebo Health Enhancement Curriculum (HEC)
Number of subjects: 0
Study: 11570939

Group type: EXPERIMENTAL
Intervention: Below-knee stocking (20-30 mm Hg)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Active stocking (30-40 mm Hg)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Untreated (control group)
Number of subjects: 202
Study: 9863994

Group type: EXPERIMENTAL
Intervention: Cold air exercise (‐10 degrees C)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Temperate air exercise (22 degrees C)
Number of subjects: 8
Study: 8165192

Group type: EXPERIMENTAL
Intervention: Sandimmune Neoral (microemulsion formulation)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sandimmune (commercial formulation)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sandimmune Neoral
Number of subjects: 48
Study: 3503451

Group type: EXPERIMENTAL
Intervention: Segmental phenolization
Number of subjects: 156

Group type: COMPARATOR
Intervention: Wedge excision
Number of subjects: 156
Study: 31297890

Group type: EXPERIMENTAL
Intervention: Breastfed infants given formula supplements
Number of subjects: 110

Group type: COMPARATOR
Intervention: Exclusively formula-fed infants
Number of subjects: 110
Study: 29354913

Group type: EXPERIMENTAL
Intervention: Auricular plaster therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Calcium supplementation
Number of subjects: 34
Study: 25299350

Group type: EXPERIMENTAL
Intervention: Extended-release tramadol HCl 75 mg/acetaminophen 650 mg (TA-ER)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Immediate-release tramadol HCl 37.5 mg/acetaminophen 325 mg (TA-IR)
Number of subjects: 320
Study: 23958154

Group type: EXPERIMENTAL
Intervention: Self-management program consisting of six group sessions and an ehealth module
Number of subjects: 142

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 142
Study: 21426839

Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Travoprost
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 63

Group type: COMPARATOR
Intervention: Latanoprost, Travoprost, Bimatoprost
Number of subjects: 63